I'm sorry, I didn't catch your name do i need a prescription for nolvadex Regulators have approved a combination of GlaxoSmithKline's Tyverb and Roche's Herceptin for use within the European Union, offering a new chemo-free option for the treatment of metastatic breast cancer.